Analystreport

Bellerophon Therapeutics Inc (NASDAQ: BLPH) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $35.00 price target on the stock.

Bellerophon Therapeutics, Inc.  (BLPH) 
Last bellerophon therapeutics, inc. earnings: 4/6 10:23 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bellerophon.com